Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina
| Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina |
| Autore | LaMattina John L |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (156 p.) |
| Disciplina |
338.4761519
615/.19 |
| Soggetto topico |
Drug development - United States
Pharmaceutical industry - United States Drugs - Research - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-118-15896-2
1-281-93930-7 9786611939304 0-470-43467-8 0-470-43465-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cholesterol drugs are unnecessary -- Industry is more interested in 'me-too' drugs than in innovation -- It takes industry too long to discover new drugs -- Drugs are discovered by academia -- New medicines add costs but little benefit -- Big pharma has failed and should learn from biotech success -- The industry invents diseases -- New drugs are less safe than traditional medicines -- Industry spends more on advertising than R&D -- Industry does not care about diseases of the developing world -- Big pharma's day has passed -- Final reflections. |
| Record Nr. | UNINA-9910144118603321 |
LaMattina John L
|
||
| Hoboken, N.J., : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina
| Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina |
| Autore | LaMattina John L |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (156 p.) |
| Disciplina |
338.4761519
615/.19 |
| Soggetto topico |
Drug development - United States
Pharmaceutical industry - United States Drugs - Research - United States |
| ISBN |
1-118-15896-2
1-281-93930-7 9786611939304 0-470-43467-8 0-470-43465-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cholesterol drugs are unnecessary -- Industry is more interested in 'me-too' drugs than in innovation -- It takes industry too long to discover new drugs -- Drugs are discovered by academia -- New medicines add costs but little benefit -- Big pharma has failed and should learn from biotech success -- The industry invents diseases -- New drugs are less safe than traditional medicines -- Industry spends more on advertising than R&D -- Industry does not care about diseases of the developing world -- Big pharma's day has passed -- Final reflections. |
| Record Nr. | UNINA-9910831068403321 |
|
LaMattina John L
|
||
| Hoboken, N.J., : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina
| Drug truths [[electronic resource] ] : dispelling the myths about pharma R&D / / John L. LaMattina |
| Autore | LaMattina John L |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (156 p.) |
| Disciplina |
338.4761519
615/.19 |
| Soggetto topico |
Drug development - United States
Pharmaceutical industry - United States Drugs - Research - United States |
| ISBN |
1-118-15896-2
1-281-93930-7 9786611939304 0-470-43467-8 0-470-43465-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cholesterol drugs are unnecessary -- Industry is more interested in 'me-too' drugs than in innovation -- It takes industry too long to discover new drugs -- Drugs are discovered by academia -- New medicines add costs but little benefit -- Big pharma has failed and should learn from biotech success -- The industry invents diseases -- New drugs are less safe than traditional medicines -- Industry spends more on advertising than R&D -- Industry does not care about diseases of the developing world -- Big pharma's day has passed -- Final reflections. |
| Record Nr. | UNINA-9910841332803321 |
|
LaMattina John L
|
||
| Hoboken, N.J., : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||